“Most companies have come out of particular biological research and picked one horse to bet on,” said John Blume in explaining his company’s approach to developing a cancer diagnostic. “We’ve built a technology platform that takes a wide-angle view and lets data tell us what wins.” Blume is the chief scientific officer of Applied Proteomics […]
An article by Chen et al., published recently in the journal Cell, offers us what Eric Topol has already dubbed “panor-omic” insight into a potential future — one in which our genomic data can be cross-correlated against other “omic” data (including transcriptomic, proteomic, metabolomic, and autoantibody profiles) to give individualized insights into our current clinical […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.